Validasi Metode Identifikasi Fenilbutazon dan Deksametason dalam Jamu Pegal Linu secara Kromatografi Lapis Tipis-Densitometri
DOI:
https://doi.org/10.61132/prosemnasikk.v1i1.4Keywords:
Adulteration, Herbal Medicine, TLCAbstract
Traditional herbal medicine, known as 'Jamu,' is prohibited from containing pharmaceutical chemical substances (BKO) by the Indonesian Food and Drug Monitoring Agency (BPOM). In October 2022, BPOM released a public warning after discovering the presence of phenylbutazone and dexamethasone in a muscle pain relief jamu product. The purpose of this research is to establish a valid method for identifying phenylbutazone and dexamethasone in jamu pegal linu. In this study, the method was applied to 10 brands of muscle pain relief jamu samples. The samples were extracted with methanol and then spotted in a quantity of 5 μl on a silica gel 60 F254 plate, eluted with a selected mobile phase, namely ethyl acetate: methanol: ammonia (8.5:1:0.5, v/v/v). Spots were observed with a densitometry at λ240 nm. Phenylbutazone appeared at Rf 0.33, and dexamethasone at Rf 0.77, with a resolution value (Rs) of 5,8. The detection limits for phenylbutazone were 8,5307 μg/ml (0,1706 mg/600 mg capsule) and for dexamethasone, 8,7611 μg/ml (0,1752/600 mg capsule). The results revealed that two samples tested positive for both phenylbutazone and dexamethasone, while six samples tested positive for dexamethasone.
Downloads
References
Appendix F: Guideline for Standard Method Performace Requirements, in: AOAC Official Method of Analysis, (2016).
KRITERIA DAN TATA LAKSANA REGISTRASI OBAT BAHAN ALAM, Pub. L. No. 25 Tahun 2023 (2023). https://ditwasotsk.pom.go.id/media/9e799d71-218f-4ee0-ba97-b749a1635a12
BPOM. (2023). Temuan Obat Tradisional dan Suplemen Kesehatan Mengandung BKO serta Kosmetik Mengandung Bahan Dilarang/Berbahaya Tahun 2023. https://www.pom.go.id/siaran-pers/temuan-obat-tradisional-dan-suplemen-kesehatan-mengandung-bko-serta-kosmetik-mengandung-bahan-dilarang-berbahaya-tahun-2023-2
Foroughi, M. H., Akhgari, M., Jokar, F., & Mousavi, Z. (2017). Identification of undeclared active pharmaceutical ingredients in counterfeit herbal medicines used as opioid substitution therapy. Australian Journal of Forensic Sciences, 49(6), 720–729. https://doi.org/10.1080/00450618.2016.1273387
Harmonised Tripartite Guideline. Q2 (R2): Validation of Analytical Procedure, (2024). https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline
KemenkesRI. (2018). Laporan Nasional Riskesdas 2018. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf
Koh, H. L., & Woo, S. O. (2000). Chinese proprietary medicine in Singapore: Regulatory control of toxic heavy metals and undeclared drugs. Drug Safety, 23(5), 351–362. https://doi.org/10.2165/00002018-200023050-00001/METRICS
Lugimbana, L., Malebo, H. M., Segeja, M. D., Akida, J. A., Malle, L. N., & Lemnge, M. M. (2006). A simple technique for the detection of anti-malarial drug formulations and their presence in human urine. Tanzania Health Research Bulletin, 8(3), 149–154. https://doi.org/10.4314/THRB.V8I3.45112
Mosy, F. F., & Kuswandani. (2019). Identifikasi Senyawa Jamu Pegal Linu yang Beredar di Kabupaten Bantul dengan Metode Kromatografi Lapis Tipis. Jurnal Ilmiah Ilmu Keperawatan Dan Ilmu Kesehatan Masyarakat, 14(1), 80–85. https://doi.org/10.32504/sm.v14i2.129
Permatasari, D., Kurniasri, N., & Muladi Putra Mahardika. (2021). Qualitative and Quantitative Analysis of Dexamethasone in Rheumatic Pain Herbal Medicine Using Thin Layer Chromatography (TLC) – Densitometry. Journal of Fundamental and Applied Pharmaceutical Science, 2(1), 11–21. https://doi.org/10.18196/jfaps.v2i1.12450
Rollando, R., Embang, E. D., & Monica, E. (2019). Penetapan Kadar Fenilbutazon dan Parasetamol Didalam Jamu Pegal Linu yang Beredar di Kota Malang Secara Kromatografi Lapis Tipis Densitometri. Jurnal Insan Farmasi Indonesia, 2(1), 126–138.
USP. (2021). General Chapter: USP. Validation of Compendial Procedure <1225>. In USP 44 - NF 39.
Xu, M., Huang, B., Gao, F., Zhai, C., Yang, Y., Li, L., Wang, W., & Shi, L. (2019). Assesment of adulterated traditional Chinese medicines in China: 2003-2017. Frontiers in Pharmacology, 10. https://doi.org/10.3389/FPHAR.2019.01446/PDF
